The PROTECT-C study is carried out in partnership with the National Health Service (NHS) England. It is run under the leadership of Professor Ranjit Manchanda, the Chief Investigator of the study. The multi-disciplinary research team includes investigators and researchers from universities and organisations across the UK and internationally (listed below). PROTECT-C is coordinated by the Barts Clinical Trials Unit, a team of cancer researchers and trial managers at Queen Mary University of London (QMUL). The study is funded by Yorkshire Cancer Research.